Q&A: What Will it Take for Clinical Proteomics to be Realized?
April 09, 2010
Q&A: What Will it Take for Clinical Proteomics to be Realized?
In a review article in Trends in Biotechnology, Pierre Lescuyer and colleagues diagnose the clinical proteomics environment and what needs to be done to bring the technology to the clinic.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Samples Available for PRG 2012 Intra-Lab QC and Reproducibility Study
January 13, 2012 / ProteoMonitor - People in the News: Eric Bouvier; Alan Marshall; and More
January 13, 2012 / ProteoMonitor - NCI Kicks Off Second Stage of Clinical Proteomic Technologies for Cancer Initiative
August 26, 2011 / ProteoMonitor - Yale-Led Group Links Protein Markers to Kidney Injury in Cardiac Surgery Patients
August 26, 2011 / ProteoMonitor - Bio-Rad Develops More Sensitive, Streamlined Workflow for SPR-Mass Spec
August 26, 2011 / ProteoMonitor